FindTrial
Sign In

Dosage effect of cisatracurium on intraoperative neuromonitoring in patients undergoing thyroid surgery

Dosage effect of cisatracurium on intraoperative neuromonitoring in patients undergoing thyroid surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900022625
Enrollment
Unknown
Registered
2019-04-19
Start date
2019-10-01
Completion date
Unknown
Last updated
2019-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thyroid cancer

Interventions

1:1*ED95 cisatracurium
2:2*ED95 cisatracurium
3:3*ED95 cisatracurium

Sponsors

Beijing Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) patients scheduled for thyroidectomy under general anesthesia; 2) ASA I~II; 3) aged 18 and 75 years old; 4) BMI<32kg/m2.

Exclusion criteria

Exclusion criteria: 1) patients who were pregnant or lactating; 2) patients with severe hypertension; 3) patients with cardiopulmonary insufficiency; 4) patients with severe cardiovascular or cerebrovascular disease; 5) patients with mental illness; 6) patients with potential risk of difficult face mask ventilation; 7) patients who were allergic to the studied drugs.

Design outcomes

Primary

MeasureTime frame
IONM signal;Cooper score;IDS score;—

Secondary

MeasureTime frame
hemodynamic response;—

Countries

China

Contacts

Public ContactLi Xiaoxi

Beijing Cancer Hospital

lixiaoxi8754@163.com+86 13426242782

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026